Clinical significance of atypical glandular cells on cervical cytology

Obstetrics and Gynecology

Volumn 107, Issue 3, 2006, Pages 701-708

  Schnatz, Peter F ^a   Guile, Matthew ^b   O'Sullivan, David M ^b   Sorosky, Joel I ^b  

^a HARTFORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ATYPICAL GLANDULAR CELLS OF UNDETERMINED SIGNIFICANCE; CANCER DIAGNOSIS; COLPOSCOPY; ENDOMETRIUM CARCINOMA; FOLLOW UP; HISTOLOGY; HUMAN; OVARY CARCINOMA; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE TUBE CARCINOMA;

ADENOCARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33646799789     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000202401.29145.68     Document Type: Review

References (36)

1. Editorial and Criteria Committees, The Bethesda System. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol 1993;37:115-23.
2. Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS, et al. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999;73:292-8.
3. Geier CS, Wilson M, Creasman W. Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol 2001;184:64-9.
4. Meath AJ, Carley ME, Wilson TO. Atypical glandular cells of undetermined significance: review of final histologic diagnoses. J Reprod Med 2002;47:249-52.
5. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Dysplasia associated with atypical glandular cells on cervical cytology. Obstet Gynecol 2005;105:494-500.
6. Nasu I, Meurer W, Fu YS. Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology. Int J Gynecol Pathol 1993;12:208-18.
7. Goff BA, Atanasoff CT, Brown E, Muntz HG, Bell DA, Rice LW. Endocervical glandular atypia in Papanicolaou smears. Obstet Gynecol 1992;79:101-4.
8. Taylor RR, Guerrieri JP, Nash JD, Henry MR, O'Connor DM. Atypical cervical cytology: colposcopic follow-up using the Bethesda System. J Reprod Med 1993;8:443-7.
9. Bucchi L, Falcini F, Schincaglia P, Desiderio F, Bondi A, Farneti M, et al. Performance indicators of organized cervical screening in Romagna (Italy). Eur J Cancer Prev 2003;12:223-8.
10. Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance: outcome predictions based on human papillomavirus testing. Am J Clinical Pathol 2004;121:87-92.
11. Chan CW, Cheung KB. Clinical significance and management of cervical atypical glandular cells of undetermined significance. Hong Kong Med J 2003;9:346-51.
12. Cheng RF, Hernandez E, Anderson LL, Heller PB, Shank R. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance. J Reprod Med 1999;44:922-8.
13. Eddy GL, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda System. Am J Obstet Gynecol 1997;177:1188-95.
14. Manetta A, Keefe K, Lin F, Ahdoot D, Kaleb V. Atypical glandular cells of undetermined significance in cervical cytologic findings. Am J Obstet Gynecol 1999;180:883-8.
15. Hecht JL, Sheets EE, Lee KR. Atypical glandular cells of undetermined significance in conventional cervical/vaginal smears and thin-layer preparations. Cancer 2002;96:1-4.
16. Reuss E, Price J, Koonings P. Atypical glandular cells of undetermined significance: subtyping as a predictor of outcome. J Reprod Med 2001;46:701-5.
17. Hammoud MM, Haefner HK, Michael CW, Ansbacher R. Atypical glandular cells of undetermined significance: histologic findings and proposed management. J Reprod Med 2002;47:266-70.
18. Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998;91:278-82.
19. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol 2000;182:1278-82.
20. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65:314-8.
21. Chhieng DC, Elgert P, Cohen JM, Cangiarella JF. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women. Cancer 2001;93:1-7.
22. Gutman G, Bachar R, Pauzner D, Lessing JB, Schejter E. Clinical evaluation of atypical glandular cells of undetermined significance upon cervical cytologic examination in Israeli Jewish women. Br J Cancer 2004;90:2194-6.
23. Wang N, Emancipator SN, Rose P, Rodriguez M, Abdul-Karim FW. Histologic follow-up of atypical cervical cells: liquid-based, thin-layer vs. conventional Pap smear. Acta Cytol 2002;46:453-7.
24. Veljovich DS, Stoler MH, Andersen WA, Covell JL, Rice LW. Atypical glandular cells of undetermined significance: a five-year retrospective histopathologic study. Am J Obstet Gynecol 1998;179:382-90.
25. Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1996;63:14-8.
26. Jeng CJ, Liang HS, Wang TY, Shen J, Yang YC, Tzeng CR. Cytologic and histologic review of atypical glandular cells (AGC) detected during cervical cytology screening. Int J Gynecol Cancer 2003;13:518-21.
27. Nasuti JF, Fleisher SR, Gupta PK. Atypical glandular cells of undetermined significance (AGUS): clinical considerations and cytohistologic correlation. Diagn Cytopathol 2002;26:186-90.
28. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF, Sorosky JI. Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology [published erratum appears in Obstet Gynecol 2005;105:1495]. Obstet Gynecol 2005;105:501-6.
29. Noller KL, Bettes B, Zinberg S, Schulkin J. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol 2003;102:259-65.
30. Smith-McCune K, Mancuso V, Contant T, Jackson R. Management of women with atypical Papanicolaou tests of undetermined significance by board-certified gynecologists: discrepancies with published guidelines. Am J Obstet Gynecol 2001;185:551-6.
31. Burja IT, Thompson SK, Sawyer WL Jr, Shurbaji MS. Atypical glandular cells of undetermined significance on cervical smears: a study with cytohistologic correlation. Acta Cytol 1999;43:351-6.
32. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-9.
33. Cox JT. ASCCP practice guidelines: management of glandular abnormalities in the cervical smear. J Lower Gen Tract Dis 1997;1:41-5.
34. Solomon D, Frable WJ, Vooijs GP, Wilbur DC, Amma NS, Collins RJ, et al. ASCUS and AGUS criteria. International Academy of Cytology Task Force summary. Diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytol 1998;42:16-24.
35. Sharpless KE, Schnatz PF, Mandavilli S, Greene JF. Sorosky JI. Lack of adherence to practice guidelines for women with atypical glandular cells on cervical cytology [erratum]. Obstet Gynecol 105:1495.
36. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.